|
n=32 |
n=137 |
n=169 |
|
Age, y, mean (SD) |
68.06(4.79) |
63.68(7.03) |
65 ± 6.9 |
<0.0001 |
Age ≥ 60 y, n (%) |
30(93.8) |
94(68.6) |
124(73.4) |
0.003 |
Level of education†, n (%) |
|
|
|
0.059 |
Up to grade 5
|
0(0.0)
|
6(5.1)
|
6 (4.1)
|
|
Up to grade 8
|
10(33.3)
|
55(46.6)
|
65 (43.9)
|
|
Up to grade 10
|
12(40.0)
|
47(39.8)
|
59 (39.9)
|
|
Up to grade 12
|
6(20.0)
|
8(6.8)
|
14 (9.5)
|
|
Graduate/ postgraduate
|
2 (6.7)
|
2(1.7)
|
4 (2.7)
|
|
Ethnicity, n (%) |
Ethnicity, n (%) |
|
|
1.000 |
Sinhalese
|
32(100)
|
135(98.8)
|
167(98.8)
|
|
Tamils
|
0 (0.0)
|
2(1.2)
|
2(1.2)
|
|
Past medical history, n (%) |
Past medical history, n
(%) |
Past medical history, n (%) |
Past medical
history, n (%) |
Past medical history, n (%) |
Hypertension |
25(78.1) |
88(64.2) |
113(66.9) |
0.150 |
Hyperlipidemia |
25(78.1) |
127(92.7) |
152(89.9) |
0.220 |
Diabetes mellitus |
20(62.5) |
59(43.1) |
79(46.7) |
0.520 |
Current smoking |
4(12.5) |
0 (0.0) |
4(2.4) |
<0.0001 |
Obesity (BMI>30) |
2(6.3) |
12(8.8) |
14(8.3) |
1.000 |
Premorbid medications, n (%) : |
Premorbid
medications, n (%) : |
Premorbid medications, n (%) : |
Premorbid medications, n (%) : |
Premorbid
medications, n (%) : |
Anti-hypertensive medications |
24(75.0) |
87(63.5) |
111(65.7) |
0.301 |
Lipid-lowering medications ‡ |
24(77.4) |
127(92.7) |
151(89.9) |
0.019 |
Anti-diabetic medication |
18(56.3) |
60(43.8) |
78(46.2) |
0.239 |
Antiplatelet medication § |
3(10.0) |
23(16.8) |
26(15.5) |
0.577 |